Bivalirudin

FLUMETASONE + SALICYLIC ACID

Flumetasone + Salicylic Acid is a corticosteroid that is applied to the skin for the treatment of different skin conditions. It has anti-inflammatory, anti-itch and anti-allergic properties. Salicylic acid can dissolve squamous skin cells and is a gentle keratolytic, hence helping transepidermal entrance of the ingredients. It likewise has some cleansing effect against microscopic organisms.

Flumetasone + Salicylic Acid  is used to treat certain skin conditions.

Flumetasone + Salicylic Acid should not be used in people with the following conditions:

  • People with allergy to Flumetasone + Salicylic Acid
  • Systemic fungal infections
  • Untreated bacterial infections
  • Tuberculosis of skin
  • Rosacea

Flumetasone + Salicylic Acid  may have the following side effects:

  • Local redness
  • Desquamation
  • Change in pigmentation
  • Pyoderma

Precautions

Take extra caution in patients with the following medical conditions:

  • Not to be used on acute weeping or subacute exudative wounds
  • Severe kidney impairment
  • Caution when used in infants and children
  • Pregnancy
  • Lactation

Interactions

Flumetasone + Salicylic Acid  may interact with the following medicines:

  • Fluocinolone
  • Hydroquinone
  • Isotretinoin
  • Tretinoin

If you think you have used Flumetasone + Clioquinol more than the usual dosage, please seek medical help immediately.

Available Brand:

  • Locasalen

Related Articles

ULTRAVIST

UsesWarningsSide EffectsPrecautionsOverdose & BrandsUses Ultravist is used in the following conditions: Radiographic Imaging: Iopromide injection is utilized to enhance the [...]

ULTRAMOX

UsesWarningsSide EffectsPrecautionsOverdose & BrandsUses Ultramox is used in the following conditions: Respiratory Infections: Amoxicillin is often used to treat respiratory [...]

ULTRALIV

UsesWarningsSide EffectsPrecautionsOverdose & BrandsUses Ultraliv is used in the following conditions: Carnitine Orotate: Carnitine orotate is a combination of L-carnitine [...]